First American Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.1M Sell
119,744
-192
-0.2% -$41.3K 1.68% 12
2026
Q1
$26.1M Buy
119,936
+1,991
+2% +$442K 1.64% 12
2025
Q4
$26.9M Buy
117,945
+82
+0.1% +$18.7K 1.63% 13
2025
Q3
$27.3M Buy
117,863
+994
+0.9% +$202K 1.71% 13
2025
Q2
$21.7M Sell
116,869
-2,403
-2% -$447K 1.49% 14
2025
Q1
$25M Buy
119,272
+812
+0.7% +$158K 1.85% 11
2024
Q4
$21.1M Buy
118,460
+823
+0.7% +$151K 1.48% 14
2024
Q3
$23.2M Sell
117,637
-2,682
-2% -$501K 1.67% 12
2024
Q2
$20.6M Sell
120,319
-639
-0.5% -$106K 1.54% 13
2024
Q1
$22M Buy
120,958
+6,569
+6% +$1.13M 1.66% 12
2023
Q4
$17.7M Buy
114,389
+950
+0.8% +$139K 1.48% 15
2023
Q3
$16.9M Buy
113,439
+88
+0.1% +$12.9K 1.53% 16
2023
Q2
$15.3M Sell
113,351
-9,135
-7% -$1.34M 1.32% 17
2023
Q1
$19.5M Sell
122,486
-965
-0.8% -$148K 1.79% 12
2022
Q4
$20M Buy
123,451
+15,421
+14% +$2.36M 1.91% 10
2022
Q3
$14.5M Buy
108,030
+19,555
+22% +$2.81M 1.51% 16
2022
Q2
$13.6M Sell
88,475
-2,177
-2% -$333K 1.38% 19
2022
Q1
$14.7M Buy
90,652
+2,404
+3% +$349K 1.24% 20
2021
Q4
$11.9M Buy
88,248
+318
+0.4% +$37.6K 0.63% 44
2021
Q3
$9.48M Sell
87,930
-247
-0.3% -$28.2K 0.55% 45
2021
Q2
$9.93M Sell
88,177
-510
-0.6% -$57.4K 0.58% 44
2021
Q1
$9.6M Buy
88,687
+350
+0.4% +$37.4K 0.6% 45
2020
Q4
$9.46M Sell
88,337
-1,541
-2% -$148K 0.63% 45
2020
Q3
$7.87M Sell
89,878
-895
-1% -$84.3K 0.47% 60
2020
Q2
$8.91M Buy
90,773
+101
+0.1% +$8.89K 0.56% 51
2020
Q1
$6.91M Buy
90,672
+846
+0.9% +$72.1K 0.51% 54
2019
Q4
$7.95M Buy
+89,826
New +$7.46M 0.5% 61
2019
Q2
$6.45M Sell
88,668
-4,884
-5% -$384K 0.44% 70
2019
Q1
$7.54M Sell
93,552
-75,218
-45% -$6.15M 0.54% 60
2018
Q4
$15.6M Sell
168,770
-7,472
-4% -$657K 1.22% 16
2018
Q3
$16.7M Buy
+176,242
New +$16.7M 1.15% 19
2018
Q1
$17.2M Buy
181,235
+318
+0.2% +$34.9K 1.3% 15
2017
Q4
$17.5M Buy
180,917
+2,047
+1% +$193K 1.33% 17
2017
Q3
$15.9M Sell
178,870
-7,377
-4% -$562K 1.21% 15
2017
Q2
$13.5M Sell
186,247
-706
-0.4% -$47.5K 1.07% 22
2017
Q1
$12.2M Sell
186,953
-14,727
-7% -$926K 0.99% 22
2016
Q4
$12.6M Sell
201,680
-7,879
-4% -$481K 1.06% 21
2016
Q3
$13.2M Buy
209,559
+6,674
+3% +$432K 1.21% 16
2016
Q2
$12.6M Sell
202,885
-25,180
-11% -$1.53M 1.21% 18
2016
Q1
$13M Sell
228,065
-6,631
-3% -$370K 1.29% 18
2015
Q4
$13.9M Buy
234,696
+1,171
+0.5% +$67.4K 1.41% 16
2015
Q3
$12.7M Sell
233,525
-47,523
-17% -$3.09M 1.39% 17
2015
Q2
$18.9M Sell
281,048
-2,435
-0.9% -$159K 1.86% 13
2015
Q1
$16.6M Buy
283,483
+690
+0.2% +$41.7K 1.63% 14
2014
Q4
$18.5M Buy
282,793
+4,988
+2% +$314K 1.96% 11
2014
Q3
$16M Buy
277,805
+9,394
+3% +$522K 1.75% 16
2014
Q2
$15.2M Buy
268,411
+3,454
+1% +$181K 1.63% 15
2014
Q1
$13.6M Buy
264,957
+64,110
+32% +$3.24M 1.51% 18
2013
Q4
$10.6M Sell
200,847
-3,690
-2% -$181K 1.21% 23
2013
Q3
$9.15M Buy
204,537
+1,685
+0.8% +$74.7K 1.13% 24
2013
Q2
$8.39M Buy
+202,852
New +$8.87M 1.16% 25

Other funds holding ABBV

First American Bank's ABBV Position: Q2 2026 in Review

First American Bank reduced its AbbVie (ABBV) stake by 0.16% in Q2 2026, selling an estimated $41.3K and leaving 119,744 shares worth $30.1M. The position accounts for 1.68% of the portfolio, ranked #12.

First American Bank first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First American Bank held 119,744 shares of AbbVie worth $30.1M as of Q2 2026.
  • First American Bank sold 192 AbbVie shares in Q2 2026, an estimated $41.3K.
  • AbbVie made up 1.68% of First American Bank's portfolio in Q2 2026, its #12 holding.
  • First American Bank first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.